性别确认激素疗法持续时间和体重指数对不同性别成年人骨矿物质密度的影响

IF 4.2 Q1 ENDOCRINOLOGY & METABOLISM
Sean J. Iwamoto , John D. Rice , Kerrie L. Moreau , Marc-André Cornier , Margaret E. Wierman , Mary P. Mancuso , Amanuail Gebregzabheir , Daniel B. Hammond , Micol S. Rothman
{"title":"性别确认激素疗法持续时间和体重指数对不同性别成年人骨矿物质密度的影响","authors":"Sean J. Iwamoto ,&nbsp;John D. Rice ,&nbsp;Kerrie L. Moreau ,&nbsp;Marc-André Cornier ,&nbsp;Margaret E. Wierman ,&nbsp;Mary P. Mancuso ,&nbsp;Amanuail Gebregzabheir ,&nbsp;Daniel B. Hammond ,&nbsp;Micol S. Rothman","doi":"10.1016/j.jcte.2024.100348","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Feminizing and masculinizing gender-affirming hormone therapy (fGAHT, mGAHT) results in bone mineral density (BMD) maintenance or improvement over time in transgender and gender diverse (TGD) adults. Mostly European TGD studies have explored GAHT’s impact on BMD, but the association of BMI and BMD in TGD adults deserves further study.</p></div><div><h3>Objective</h3><p>To determine whether GAHT duration or BMI are associated with BMD and Z-scores among TGD young adults.</p></div><div><h3>Methods</h3><p>Cross-sectional study of nonsmoking TGD adults aged 18–40 years without prior gonadectomy or gonadotropin-releasing hormone agonist (GnRHa) therapy taking GAHT for &gt; 1 year. BMD and Z-scores were collected from dual-energy x-ray absorptiometry. Associations between femoral neck, total hip, and lumbar spine BMDs and Z-scores and the predictors, GAHT duration and BMI, were estimated using linear regression.</p></div><div><h3>Results</h3><p>Among 15 fGAHT and 15 mGAHT, mean BMIs were 27.6 +/- standard deviation (SD) 6.4 kg/m<sup>2</sup> and 25.3 +/- 5.9 kg/m<sup>2</sup>, respectively. Both groups had mean BMDs and Z-scores within expected male and female reference ranges at all three sites. Higher BMI among mGAHT was associated with higher femoral neck and total hip BMDs (femoral neck: β = 0.019 +/- standard error [SE] 0.007 g/cm<sup>2</sup>, total hip: β = 0.017 +/- 0.006 g/cm<sup>2</sup>; both p &lt; 0.05) and Z-scores using male and female references. GAHT duration was not associated with BMDs or Z-scores for either group.</p></div><div><h3>Conclusions</h3><p>Z-scores in young, nonsmoking TGD adults taking GAHT for &gt; 1 year, without prior gonadectomy or GnRHa, and with mean BMIs in the overweight range, were reassuringly within the expected ranges for age based on male and female references. Higher BMI, but not longer GAHT duration, was associated with higher femoral neck and total hip BMDs and Z-scores among mGAHT. Larger, prospective studies are needed to understand how body composition changes, normal or low BMIs, and gonadectomy affect bone density in TGD adults.</p></div>","PeriodicalId":46328,"journal":{"name":"Journal of Clinical and Translational Endocrinology","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221462372400019X/pdfft?md5=9da660886ea8d958e187bf2fab569fd2&pid=1-s2.0-S221462372400019X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The association of gender-affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults\",\"authors\":\"Sean J. Iwamoto ,&nbsp;John D. Rice ,&nbsp;Kerrie L. Moreau ,&nbsp;Marc-André Cornier ,&nbsp;Margaret E. Wierman ,&nbsp;Mary P. Mancuso ,&nbsp;Amanuail Gebregzabheir ,&nbsp;Daniel B. Hammond ,&nbsp;Micol S. Rothman\",\"doi\":\"10.1016/j.jcte.2024.100348\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Feminizing and masculinizing gender-affirming hormone therapy (fGAHT, mGAHT) results in bone mineral density (BMD) maintenance or improvement over time in transgender and gender diverse (TGD) adults. Mostly European TGD studies have explored GAHT’s impact on BMD, but the association of BMI and BMD in TGD adults deserves further study.</p></div><div><h3>Objective</h3><p>To determine whether GAHT duration or BMI are associated with BMD and Z-scores among TGD young adults.</p></div><div><h3>Methods</h3><p>Cross-sectional study of nonsmoking TGD adults aged 18–40 years without prior gonadectomy or gonadotropin-releasing hormone agonist (GnRHa) therapy taking GAHT for &gt; 1 year. BMD and Z-scores were collected from dual-energy x-ray absorptiometry. Associations between femoral neck, total hip, and lumbar spine BMDs and Z-scores and the predictors, GAHT duration and BMI, were estimated using linear regression.</p></div><div><h3>Results</h3><p>Among 15 fGAHT and 15 mGAHT, mean BMIs were 27.6 +/- standard deviation (SD) 6.4 kg/m<sup>2</sup> and 25.3 +/- 5.9 kg/m<sup>2</sup>, respectively. Both groups had mean BMDs and Z-scores within expected male and female reference ranges at all three sites. Higher BMI among mGAHT was associated with higher femoral neck and total hip BMDs (femoral neck: β = 0.019 +/- standard error [SE] 0.007 g/cm<sup>2</sup>, total hip: β = 0.017 +/- 0.006 g/cm<sup>2</sup>; both p &lt; 0.05) and Z-scores using male and female references. GAHT duration was not associated with BMDs or Z-scores for either group.</p></div><div><h3>Conclusions</h3><p>Z-scores in young, nonsmoking TGD adults taking GAHT for &gt; 1 year, without prior gonadectomy or GnRHa, and with mean BMIs in the overweight range, were reassuringly within the expected ranges for age based on male and female references. Higher BMI, but not longer GAHT duration, was associated with higher femoral neck and total hip BMDs and Z-scores among mGAHT. Larger, prospective studies are needed to understand how body composition changes, normal or low BMIs, and gonadectomy affect bone density in TGD adults.</p></div>\",\"PeriodicalId\":46328,\"journal\":{\"name\":\"Journal of Clinical and Translational Endocrinology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S221462372400019X/pdfft?md5=9da660886ea8d958e187bf2fab569fd2&pid=1-s2.0-S221462372400019X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical and Translational Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221462372400019X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221462372400019X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

导言女性化和男性化的性别肯定激素疗法(fGAHT、mGAHT)可使变性和性别多元化(TGD)成年人的骨矿物质密度(BMD)随着时间的推移得到维持或改善。方法对年龄在 18-40 岁、未接受过性腺切除术或促性腺激素释放激素激动剂(GnRHa)治疗的非吸烟 TGD 成年人进行横断面研究,这些人接受 GAHT 治疗 > 1 年。双能 X 射线吸收测量法收集了 BMD 和 Z 值。采用线性回归法估算股骨颈、全髋、腰椎 BMD 和 Z 值与预测因素(GAHT 持续时间和 BMI)之间的关系。结果在 15 名 fGAHT 和 15 名 mGAHT 中,平均 BMI 分别为 27.6 +/- 标准差 (SD) 6.4 kg/m2 和 25.3 +/- 5.9 kg/m2。在所有三个部位,两组的平均 BMD 和 Z 值均在预期的男性和女性参考范围内。mGAHT 中较高的 BMI 与较高的股骨颈和全髋 BMD 相关(股骨颈:β = 0.019 +/- 标准误差 [SE] 0.007 g/cm2,全髋:β = 0.017 +/- 0.006 g/cm2;均 p < 0.05),Z-scores 采用男性和女性参考值。结论 Z-scores(Z-scores)在服用 GAHT 1 年的年轻非吸烟 TGD 成年人中令人欣慰,他们之前未接受过性腺切除术或 GnRHa,平均体重指数在超重范围内,根据男性和女性参考值,Z-scores 在预期的年龄范围内。在 mGAHT 中,较高的体重指数(而非较长的 GAHT 持续时间)与较高的股骨颈和全髋 BMD 及 Z 值相关。需要进行更大规模的前瞻性研究,以了解身体成分变化、正常或较低的体重指数以及性腺切除术如何影响 TGD 成年人的骨密度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The association of gender-affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults

Introduction

Feminizing and masculinizing gender-affirming hormone therapy (fGAHT, mGAHT) results in bone mineral density (BMD) maintenance or improvement over time in transgender and gender diverse (TGD) adults. Mostly European TGD studies have explored GAHT’s impact on BMD, but the association of BMI and BMD in TGD adults deserves further study.

Objective

To determine whether GAHT duration or BMI are associated with BMD and Z-scores among TGD young adults.

Methods

Cross-sectional study of nonsmoking TGD adults aged 18–40 years without prior gonadectomy or gonadotropin-releasing hormone agonist (GnRHa) therapy taking GAHT for > 1 year. BMD and Z-scores were collected from dual-energy x-ray absorptiometry. Associations between femoral neck, total hip, and lumbar spine BMDs and Z-scores and the predictors, GAHT duration and BMI, were estimated using linear regression.

Results

Among 15 fGAHT and 15 mGAHT, mean BMIs were 27.6 +/- standard deviation (SD) 6.4 kg/m2 and 25.3 +/- 5.9 kg/m2, respectively. Both groups had mean BMDs and Z-scores within expected male and female reference ranges at all three sites. Higher BMI among mGAHT was associated with higher femoral neck and total hip BMDs (femoral neck: β = 0.019 +/- standard error [SE] 0.007 g/cm2, total hip: β = 0.017 +/- 0.006 g/cm2; both p < 0.05) and Z-scores using male and female references. GAHT duration was not associated with BMDs or Z-scores for either group.

Conclusions

Z-scores in young, nonsmoking TGD adults taking GAHT for > 1 year, without prior gonadectomy or GnRHa, and with mean BMIs in the overweight range, were reassuringly within the expected ranges for age based on male and female references. Higher BMI, but not longer GAHT duration, was associated with higher femoral neck and total hip BMDs and Z-scores among mGAHT. Larger, prospective studies are needed to understand how body composition changes, normal or low BMIs, and gonadectomy affect bone density in TGD adults.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.10
自引率
0.00%
发文量
24
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信